HCPCS Level II Q2036: Influenza Vaccine (Flulaval) IM, Age 3+
HCPCS Level II code Q2036 describes the influenza virus vaccine, split virus (Flulaval), indicated for intramuscular administration to individuals aged 3 years and older; the service is a vaccine administration for influenza prevention, typically provided in outpatient clinics, physician offices, pharmacies, and other ambulatory care settings as an intramuscular injection.
For related coverage guidance, see recent payer policy updates: Truvada (Emtricitabine and Tenofovir Disoproxil Fumarate) for HIV Prevention and Treatment, HIV/AIDS Pharmacologic Prevention and Treatment, Long-Acting Injectable Antiretroviral Agents for HIV.
Customize your policy alerts
Sign up for hcpcs Q2036 policy alerts
Get alerted when payer policies referencing Q2036 are released or updated.
Monitor payer policy activity